Protective role of antioxidants in diabetes-induced cardiac dysfunction

Cardiovascular Toxicology

Volumn 10, Issue 2, 2010, Pages 73-86

  Vassort, Guy ^a   Turan, Belma ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Doxycycline; Heart function; Hyperglycemia; Intracellular calcium ion; Oxidative stress; Reactive nitrogen species; Reactive oxygen species; Selenium

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; CATALASE; CREATINE PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE PEROXIDASE; OMEGA 3 FATTY ACID; PIOGLITAZONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; SELENIUM; SODIUM SELENITE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; ZINC; ZINC ION;

ANTIOXIDANT ACTIVITY; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; REVIEW; SEX DIFFERENCE; STREPTOZOCIN DIABETES; ANIMAL; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DRUG EFFECTS; ETIOLOGY; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PREVENTION AND CONTROL;

ANIMALS; ANTIOXIDANTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 77956392193     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-010-9064-0     Document Type: Review

References (137)

1. Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972). New type of cardiomyopathy associated with diabetic glomerulosclerosis. American Journal of Cardiology, 30(6), 595-602.
2. Fox, C. S., Coady, S., Sorlie, P. D., D'Agostino, R. B., Pencina, M. J., Vasan, R. S., et al. (2007). Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study. Circulation, 115(12), 1544-1550.
3. Poornima, I. G., Parikh, P., & Shanno, R. P. (2006). Diabetic cardiomyopathy: The search for a unifying hypothesis. Circulation Research, 98(5), 596-605.
4. Karamitsos, T. D., Karvounis, H. I., Dalamanga, E. G., Papadopoulos, C. E., Didangellos, T. P., Karamitsos, D. T., et al. (2007). Early diastolic impairment of diabetic heart: The significance of right ventricle. International Journal of Cardiology, 114(2), 218-223.
5. Zarich, S. W., Arbuckle, B. E., Cohen, L. R., Roberts, M., & Nesto, R. W. (1988). Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. Journal of the American College of Cardiology, 12(1), 114-120.
6. 2+ in the heart during diabetes. Cardiovascular Research, 34, 41-47.
7. Xu, Z., Patel, K. P., Lou, M. F., & Rozanski, G. J. (2002). Upregulation of K(+) channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovascular Research, 53, 80-88.
8. Ayaz, M., Ozdemir, S., Ugur, M., Vassort, G., & Turan, B. (2004). Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Archives of Biochemistry and Biophysics, 426(1), 83-90.
9. Ayaz, M., & Turan, B. (2006). Selenium prevents diabetesinduced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. American Journal of Physiology Heart and Circulatory Physiology, 290(3), H1071-H1080.
10. Boudina, S., & Abel, E. D. (2007). Diabetic cardiomyopathy revisited. Circulation, 115(25), 3213-3223.
11. Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54(6), 1615-1625.
12. Ceriello, A. (2003). New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care, 26(5), 1589-1596.
13. Forstermann, U. (2008). Oxidative stress in vascular disease: Causes, defence mechanisms and potential therapies. Nature Clinical Practice Cardiovascular Medicine, 5(6), 338-349.
14. Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005). Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovascular Diabetology, 4(1), 5-11.
15. Rahangdale, S., Yeh, S. Y., Malhotra, A., & Veves, A. (2009). Therapeutic interventions and oxidative stress in diabetes. Frontiers in Bioscience, 14, 192-209.
16. An, D., & Rodrigues, B. (2006). Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. American Journal of Physiology Heart and Circulatory Physiology, 291(4), H1489-H1506.
17. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews, 2, CD007176.
18. Flores-Mateo, G., Navas-Acien, A., Pastor-Barriuso, R., & Guallar, E. (2006). Selenium and coronary heart disease: A meta-analysis. American Journal of Clinical Nutrition, 84(4), 762-773.
19. Choi, K. M., Zhong, Y., Hoit, B. D., Grupp, I. L., Hahn, H., Dilly, K. W., et al. (2002). Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. American Journal of Physiology Heart and Circulatory Physiology, 283(4), H1398-H1408.
20. Lagadic-Gossmann, D., Buckler, K. J., Le Prigent, K., & Feuvray, D. (1996). Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats. American Journal of Physiology, 270(5 Pt 2), H1529-H1537.
21. Ren, J., & Davidoff, A. J. (1997). Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. American Journal of Physiology, 272(1 Pt 2), H148-H158.
22. Pereira, L., Matthes, J., Schuster, I., Valdivia, H. H., Herzig, S., Richard, S., et al. (2006). Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes, 55(3), 608-615.
23. Bidasee, K. R., Nallani, K., Besch, H. R., & Dincer, U. D. (2003). Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). Journal of Pharmacology and Experimental Therapeutics, 305(3), 989-998.
24. Yaras, N., Ugur, M., Ozdemir, S., Gurdal, H., Purali, N., Lacampagne, A., et al. (2005). Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes, 54(11), 3082-3088.
25. Yaras, N., Tuncay, E., Purali, N., Sahinoglu, B., Vassor, G., & Turan, B. (2007). Sex-related effects on diabetes-induced alterations in calcium release in the rat heart. American Journal of Physiology Heart and Circulatory Physiology, 293(6), H3584-H3592.
26. Fauconnier, J., Lanner, J. T., Zhang, S. J., Tavi, P., Bruton, J. D., Kat, Z. A., et al. (2005). Insulin and inositol 1, 4, 5-trisphosphate trigger abnormal cytosolic Ca2+ transients and reveal mitochondrial Ca2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes, 54(8), 2375-2381.
27. Lebeche, D., Davidoff, A. J., & Hajjar, R. J. (2008). Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nature Clinical Practice Cardiovascular Medicine, 5(11), 715-724.
28. Zhang, L., Cannell, M. B., Phillips, A. R., Cooper, G. J., & Ward, M. L. (2008). Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy. Diabetes, 57(8), 2158-2166.
29. Hertelendi, Z., Toth, A., Borbely, A., Galajda, Z., van der Velden, J., Stienen, G. J., et al. (2008). Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and its Ca2+ sensitivity in human cardiomyocytes. Antioxid. Redox Signal, 10(7), 1175-1184.
30. Schulz, R., Dodge, K. L., Lopaschuk, G. D., & Clanachan, A. S. (1997). Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. American Journal of Physiology, 272(3 Pt 2), H1212-H1219.
31. Turan, B., Desilets, M., Acan, L. N., Hotomaroglu, O., Vannier, C., & Vassort, G. (1996). Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovascular Research, 32(2), 351-361.
32. Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., et al. (2006). NADPH oxidases in cardiovascular health and disease. Antioxidants & Redox Signaling, 8(5-6), 691-728.
33. Berry, C., Hamilto, C. A., Brosnan, M. J., Magill, F. G., Berg, G. A., McMurray, J. J., et al. (2000). Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation, 101(18), 2206-2212.
34. He, X., Kan, H., Cai, L., & Ma, Q. (2009). Nrf2 is critical in defence against high glucose-induced oxidative damage in cardiomyocytes. Journal of Molecular and Cellular Cardiology, 46(1), 47-58.
35. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404(6779), 787-790.
36. Yamawaki, H., & Berk, B. C. (2005). Thioredoxin: A multifunctional antioxidant enzyme in kidney, heart and vessels. Current Opinion in Nephrology and Hypertension, 14(2), 149-153.
37. Tuncay, E., Seymen, A. A., Tanriverdi, E., Yaras, N., Tandogan, B., Ulusu, N. N., et al. (2007). Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Molecular and Cellular Biochemistry, 304(1-2), 255-263.
38. Kakkar, R., Kalra, J., Mantha, S. V., & Prasad, K. (1995). Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Molecular and Cellular Biochemistry, 151(2), 113-119.
39. Okutan, H., Ozcelik, N., Yilmaz, H. R., & Uz, E. (2005). Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clinical Biochemistry, 38(2), 191-196.
40. Yadav, P., Sarkar, S., & Bhatnagar, D. (1997). Action of capparis decidua against alloxan-induced oxidative stress and diabetes in rat tissues. Pharmacological Research, 36(3), 221-228.
41. Hamblin, M., Friedman, D. B., Hill, S., Caprioli, R. M., Smith, H. M., & Hill, M. F. (2007). Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. Journal of Molecular and Cellular Cardiology, 42(4), 884-895.
42. Stockklauser-Farber, K., Ballhausen, T., Laufer, A., & Rosen, P. (2000). Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochimica et Biophysica Acta, 1535(1), 10-20.
43. Meininger, C. J., Marinos, R. S., Hatakeyama, K., Martinez-Zaguilan, R., Rojas, J. D., Kelly, K. A., et al. (2000). Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochemical Journal, 349(Pt 1), 353-356.
44. Zhen, J., Lu, H., Wang, X. Q., Vaziri, N. D., & Zhou, X. J. (2008). Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. American Journal of Hypertension, 21(1), 28-34.
45. Vinten-Johansen, J. (2000). Physiological effects of peroxynitrite: Potential products of the environment. Circulation Research, 87(3), 170-172.
46. Turko, I. V., Li, L., Aulak, K. S., Stuehr, D. J., Chang, J. Y., & Murad, F. (2003). Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. The Journal of Biological Chemistry, 278(36), 33972-33977.
47. Peluffo, G., & Radi, R. (2007). Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovascular Research, 75(2), 291-302.
48. Pacher, P., Obrosova, I. G., Mabley, J. G., & Szabo, C. (2005). Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Current Medicinal Chemistry, 12(3), 267-275.
49. Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E. H., Anversa, P., Leri, A., et al. (2000). Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Laboratory Investigation, 80(4), 513-527.
50. Malhotra, A., Kang, B. P., Cheung, S., Opawumi, D., & Meggs, L. G. (2001). Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes, 50(8), 1918-1926.
51. Sechi, L. A., Griffin, C. A., & Schambelan, M. (1994). The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes, 43(10), 1180-1184.
52. Bendall, J. K., Cave, A. C., Heymes, C., Gall, N., & Shah, A. M. (2002). Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation, 105(3), 293-296.
53. Griendling, K. K., & Ushio-Fukai, M. (2000). Reactive oxygen species as mediators of angiotensin II signaling. Regulatory Peptides, 91(1-3), 21-27.
54. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., et al. (1996). Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Journal of Clinical Investigation, 97(8), 1916-1923.
55. Tsutsui, H., Matsushima, S., Kinugawa, S., Ide, T., Inoue, N., Ohta, Y., et al. (2007). Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Hypertension Research, 30(5), 439-449.
56. Rahman, M., Kimura, S., Nishiyama, A., Hitomi, H., Zhang, G., & Abe, Y. (2004). Angiotensin II stimulates superoxide production via both angiotensin AT1A and AT1B receptors in mouse aorta and heart. European Journal of Pharmacology, 485(1-3), 243-249.
57. Ricci, C., Pastukh, V., Leonard, J., Turrens, J., Wilson, G., Schaffer, D., et al. (2008). Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. American Journal of Physiology Cell Physiology, 294(2), C413-C422.
58. Yaras, N., Bilginoglu, A., Vassort, G., & Turan, B. (2007). Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade. American Journal of Physiology Heart and Circulatory Physiology, 292(2), H912-H920.
59. Aasum, E., Belke, D. D., Severson, D. L., Riemersma, R. A., Cooper, M., Andreassen, M., et al. (2002). Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator. American Journal of Physiology Heart and Circulatory Physiology, 283(3), H949-H957.
60. Da Ros, R., Assaloni, R., & Ceriello, A. (2004). The preventive anti-oxidant action of thiazolidinediones: A new therapeutic prospect in diabetes and insulin resistance. Diabetic Medicine, 21(11), 1249-1252.
61. van der Meer, R. W., Rijzewijk, L. J., de Jong, H. W., Lamb, H. J., Lubberink, M., Romijn, J. A., et al. (2009). Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with wellcontrolled type 2 diabetes mellitus. Circulation, 119(15), 2069-2077.
62. von Bibra, H., Diamant, M., Scheffer, P. G., Siegmund, T., & Schumm-Draeger, P. M. (2008). Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease. Diabetes & Vascular Disease Research, 5(4), 310-318.
63. Lumini, J. A., Magalhaes, J., Oliveira, P. J., & Ascensao, A. (2008). Beneficial effects of exercise on muscle mitochondrial function in diabetes mellitus. Sports Medicine, 38(9), 735-750.
64. Berg, E. A., Wu, J. Y., Campbell, L., Kagey, M., & Stapleton, S. R. (1995). Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie, 77(12), 919-924.
65. Ayaz, M., Can, B., Ozdemir, S., & Turan, B. (2002). Protective effect of selenium treatment on diabetes-induced myocardial structural alterations. Biological Trace Element Research, 89, 215-226.
66. Ulusu, N. N., & Turan, B. (2005). Beneficial effects of selenium on some enzymes of diabetic rat heart. Biological Trace Element Research, 103(3), 207-216.
67. Aydemir-Koksoy, A., Bilginoglu, A., Sariahmetoglu, M., Schulz, R., Turan, B. (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. The Journal of Nutritional Biochemistry [Epub ahead of print].
68. Korichneva, I. (2006). Zinc dynamics in the myocardial redox signaling network. Antioxidants & Redox Signaling, 8(9-10), 1707-1721.
69. Dinele, Y. K. E., Richards, L. L., Votyakova, T. V., & Reynolds, I. J. (2005). Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion, 5(1), 55-65.
70. Gazaryan, I. G., Krasinskaya, I. P., Kristal, B. S., & Brown, A. M. (2007). Zinc irreversibly damages major enzymes of energy production and antioxidant defence prior to mitochondrial permeability transition. The Journal of Biological Chemistry, 282(33), 24373-24380.
71. Turan, B., Fliss, H., & Desilets, M. (1997). Oxidants increase intracellular free Zn2+ concentration in rabbit ventricular myocytes. American Journal of Physiology, 272(5 Pt 2), H2095-H2106.
72. Song, Y., Wang, J., Li, X. K., & Cai, L. (2005). Zinc and the diabetic heart. BioMetals, 18(4), 325-332.
73. Noh, S. K., & Koo, S. I. (2001). Feeding of a low-zinc diet lowers the tissue concentrations of alpha-tocopherol in adult rats. Biological Trace Element Research, 81(2), 153-168.
74. Maret, W., & Sandstead, H. H. (2006). Zinc requirements and the risks and benefits of zinc supplementation. Journal of Trace Elements in Medicine and Biology, 20(1), 3-18.
75. Roussel, A. M., Kerkeni, A., Zouari, N., Mahjoub, S., Matheau, J. M., & Anderson, R. A. (2003). Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. Journal of the American College of Nutrition, 22(4), 316-321.
76. Prasad, A. S., Bao, B., Beck, F. W., Kucuk, O., & Sarkar, F. H. (2004). Antioxidant effect of zinc in humans. Free Radical Biology and Medicine, 37(8), 1182-1190.
77. Zou, M. H., Shi, C., & Cohen, R. A. (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. Journal of Clinical Investigation, 109(6), 817-826.
78. Ali, M. M., Frei, E., Straub, J., Breuer, A., & Wiessler, M. (2002). Induction of metallothionein by zinc protects from daunorubicin toxicity in rats. Toxicology, 179(1-2), 85-93.
79. Wang, J., Song, Y., Elsherif, L., Song, Z., Zhou, G., Prabhu, S. D., et al. (2006). Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation, 113(4), 544-554.
80. Szabo, C., Mabley, J. G., Moeller, S. M., Shimanovich, Rç., Pacher, P., Virag, L., et al. (2002). Part I: Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: Studies with FP15, a novel potent peroxynitrite decomposition catalyst. Molecular Medicine, 8(10), 571-580.
81. Privratsky, J. R., Wol, L. E., Sowers, J. R., Quinn, M. T., & Ren, J. (2003). AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: Role of the AT1 receptor and NADPH oxidase. Hypertension, 42(2), 206-212.
82. Brown, L., Wall, D., Marchant, C., & Sernia, C. (1997). Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. Journal of Endocrinology, 154(2), 355-362.
83. Shekelle, P. G., Rich, M. W., Morton, S. C., Atkinson, C. S., Tu, W., Maglione, M., et al. (2003). Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials. Journal of the American College of Cardiology, 41(9), 1529-1538.
84. Shimoni, Y., Hunt, D., Chuang, M., Chen, K. Y., Kargacin, G., & Severson, D. L. (2005). Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat. Journal of Physiology, 567(Pt 1), 177-190.
85. Raimondi, L., De Paoli, P., Mannucci, E., Lonardo, G., Sartiani, L., Banchelli, G., et al. (2004). Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes, 53(7), 1927-1933.
86. Ozdemir, S., Tandogan, B., Ulusu, N. N., & Turan, B. (2009). Angiotensin II receptor blockage prevents diabetes-induced oxidative damage in rat heart. Folia Biologica, 55(1), 11-16.
87. Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., et al. (2002). Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet, 359(9311), 995-1003.
88. Kajstura, J., Fiordaliso, F., Andreoli, A. M., Li, B., Chimenti, S., Medow, M. S., et al. (2001). IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes, 50(6), 1414-1424.
89. Zhou, G., Li, X., Hein, D. W., Xiang, X., Marshall, J. P., Prabhu, S. D., et al. (2008). Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. Journal of the American College of Cardiology, 52(8), 655-666.
90. Ding, Y., Zou, R., Judd, R. L., & Zhong, J. (2006). Endothelin-1 receptor blockade prevented the electrophysiological dysfunction in cardiac myocytes of streptozotocin-induced diabetic rats. Endocrine, 30(1), 121-127.
91. Shimoni, Y., Chen, K., Emmett, T., & Kargacin, G. (2008). Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart. British Journal of Pharmacology, 154(3), 675-687.
92. Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002). Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism, 87(3), 978-982.
93. Marfella, R., Di Filippo, C., Esposito, K., Nappo, F., Piegari, E., Cuzzocrea, S., et al. (2004). Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes, 53(2), 454-462.
94. Registered, A., Login, P., Options, P., & Access, S. D. (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet, 54(9177), 447-455.
95. Lonn, E., Bosch, J., Yusuf, S., Sheridan, P., Pogue, J., Arnold, J. M., et al. (2005). Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA, 293(11), 1338-13247.
96. Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003). Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. The Journal of Nutritional Biochemistry, 14(5), 288-294.
97. Yamamoto, M., Yang, G., Hong, C., Liu, J., Holle, E., Yu, X., et al. (2003). Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. Journal of Clinical Investigation, 112(9), 1395-1406.
98. Iwata, K., Nishinak, T., Matsuno, K., Kakehi, T., Katsuyama, M., Ibi, M., et al. (2007). The activity of aldose reductase is elevated in diabetic mouse heart. Journal of Pharmacological Sciences, 103(4), 408-416.
99. Kakkar, R., Mantha, S. V., Kalra, J., & Prasad, K. (1996). Time course study of oxidative stress in aorta and heart of diabetic rat. Clinical Science (London), 91(4), 441-448.
100. Guo, Z., Xia, Z., Jiang, J., & McNeill, J. H. (2007). Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. American Journal of Physiology Heart and Circulatory Physiology, 292(4), H1728-H1736.
101. Xia, Z., Guo, Z., Nagareddy, P. R., Yuen, V., Yeung, E., & McNeill, J. H. (2006). Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. European Journal of Pharmacology, 544(1-3), 118-125.
102. Ramasamy, R., Oates, P. J., & Schaefer, S. (1997). Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes, 46(2), 292-300.
103. Shen, X., Zheng, S., Metreveli, N. S., & Epstein, P. N. (2006). Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes, 55(3), 798-805.
104. Di Filippo, C., Cuzzocrea, S., Marfella, R., Fabbroni, V., Scollo, G., Berrino, L., et al. (2004). M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart. European Journal of Pharmacology, 497(1), 65-74.
105. Schaffer, S. W., Azuma, J., & Mozaffari, M. (2009). Role of antioxidant activity of taurine in diabetes. Canadian Journal of Physiology and Pharmacology, 87(2), 91-99.
106. Ye, G., Metreveli, N. S., Donthi, R. V., Xia, S., Xu, M., Carlson, E. C., et al. (2004). Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes, 53(5), 1336-1343.
107. Cai, L. (2007). Diabetic cardiomyopathy and its prevention by metallothionein: Experimental evidence, possible mechanisms and clinical implications. Current Medicinal Chemistry, 14(20), 2193-2203.
108. Ye, G., Metreveli, N. S., Ren, J., & Epstein, P. N. (2003). Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes, 52(3), 777-783.
109. Wold, L. E., Ceylan-Isik, A. F., Fang, C. X., Yang, X., Li, S. Y., Sreejayan, N., et al. (2006). Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radical Biology and Medicine, 40(8), 1419-1429.
110. Lemaitre, V., & D'Armiento, J. (2006). Matrix metalloproteinases in development and disease. Birth Defects Research. Part C, Embryo Today: Reviews, 78(1), 1-10.
111. Yaras, N., Sariahmetoglu, M., Bilginoglu, A., Aydemir-Koksoy, A., Onay-Besikci, A., Turan, B., et al. (2008). Protective action of doxycycline against diabetic cardiomyopathy in rats. British Journal of Pharmacology, 155(8), 1174-1184.
112. Bilginoglu, A., Seymen, A., Tuncay, E., Zeydanli, E., Aydemir-Koksoy, A., & Turan, B. (2009). Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats. Cardiovascular Toxicology, 9(1), 21-29.
113. Laczy, B., Hill, B. G., Wang, K., Paterson, A. J., White, C. R., Xing, D., et al. (2009). Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system. American Journal of Physiology Heart and Circulatory Physiology, 296(1), H13-H28.
114. Clark, R. J., McDonough, P. M., Swanson, E., Trost, S. U., Suzuki, M., Fukuda, M., et al. (2003). Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. The Journal of Biological Chemistry, 278(45), 44230-44237.
115. Hu, Y., Belke, D., Suarez, J., Swanson, E., Clark, R., Hoshijima, M., et al. (2005). Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circulation Research, 96(9), 1006-1013.
116. Baines, C. P., Goto, M., & Downey, J. M. (1997). Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. Journal of Molecular and Cellular Cardiology, 29(1), 207-216.
117. Carroll, R., Gant, V. A., & Yellon, D. M. (2001). Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovascular Research, 51(4), 691-700.
118. Vanden Hoek, T. L., Becker, L. B., Shao, Z., Li, C., & Schumacker, P. T. (1998). Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. The Journal of Biological Chemistry, 273(29), 18092-18098.
119. Hassouna, A., Loubani, M., Matata, B. M., Fowler, A., Standen, N. B., & Galinanes, M. (2006). Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovascular Research, 69(2), 450-458.
120. Watanabe, M., Wu, J., Li, S., Li, C., & Okada, T. (2004). Mechanisms of cardioprotective effects of magnesium on hypoxia-reoxygenation-induced injury. Experimental and Clinical Cardiology, 9(3), 181-185.
121. Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974). Role of diabetes in congestive heart failure: The Framingham study. American Journal of Cardiology, 34(1), 29-34.
122. Marra, G., Cotroneo, P., Pitocco, D., Manto, A., Di Leo, M. A., Ruotolo, V., et al. (2002). Early increase of oxidative stress and reduced antioxidant defences in patients with uncomplicated type 1 diabetes: A case for gender difference. Diabetes Care, 25(2), 370-375.
123. Regitz-Zagrosek, V., Brokat, S., & Tschope, C. (2007). Role of gender in heart failure with normal left ventricular ejection fraction. Progress in Cardiovascular Diseases, 49(4), 241-251.
124. Shimoni, Y., Chuang, M., Abel, E. D., & Severson, D. L. (2004). Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. Journal of Physiology, 555(Pt 2), 345-354.
125. Shimoni, Y., & Liu, X. F. (2004). Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats. American Journal of Physiology Heart and Circulatory Physiology, 287(1), H311-H319.
126. Berg, T. J., Snorgaard, O., Faber, J., Torjesen, P. A., Hildebrandt, P., Mehlsen, J., et al. (1999). Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care, 22(7), 1186-1190.
127. Digerness, S. B., Harris, K. D., Kirklin, J. W., Urthaler, F., Viera, L., Beckman, J. S., et al. (1999). Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radical Biology and Medicine, 27(11-12), 1386-1392.
128. Siegmund, T., Schumm-Draeger, P. M., Antoni, D., & Bibra, H. V. (2007). Beneficial effects of ramipril on myocardial diastolic function in patients with type 2 diabetes mellitus, normal LV systolic function and without coronary artery disease: A prospective study using tissue Doppler. Diabetes & Vascular Disease Research, 4(4), 358-364.
129. Chen, Y., Ohmori, K., Mizukawa, M., Yoshida, J., Zeng, Y., Zhang, L., et al. (2007). Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes. Circulation Journal, 71(1), 144-152.
130. Yu, Y., Ohmori, K., Chen, Y., Sato, C., Kiyomoto, H., Shinomiya, K., et al. (2004). Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model. Journal of the American College of Cardiology, 44(4), 904-913.
131. Kruger, M., Kotter, S., Grutzner, A., Lang, P., Andresen, C., Redfield, M. M., et al. (2009). Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circulation Research, 104(1), 87-94.
132. Flarsheim, C. E., Grupp, I. L., & Matlib, M. A. (1996). Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. American Journal of Physiology, 71(2), H192-H202.
133. Oliveira, P. J., Seica, R., Coxito, P. M., Rolo, A. P., Palmeira, C. M., Santos, M. S., et al. (2003). Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats. FEBS Letter, 554(3), 511-514.
134. Diamant, M., Lamb, H. J., Groeneveld, Y., Endert, E. L., Smit, J. W., Bax, J. J., et al. (2003). Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. Journal of the American College of Cardiology, 42(2), 328-335.
135. Scheuermann-Freestone, M., Madsen, P. L., Manners, D., Blamire, A. M., Buckingham, R. E., Styles, P., et al. (2003). Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation, 107(24), 3040-3046.
136. Mihm, M. J., Yu, F., Reiser, P. J., & Bauer, J. A. (2003). Effects of peroxynitrite on isolated cardiac trabeculae: Selective impact on myofibrillar energetic controllers. Biochimie, 85(6), 587-596.
137. Duncan, J. G., Fong, J. L., Medeiros, D. M., Finck, B. N., & Kelly, D. P. (2007). Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation, 115(7), 909-917.